Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
GFAP Blocking Peptide (AC1346)
Cat.#: ACPP-1346
Specifications
Despition GFAP Blocking Peptide for Immunodepletion, Immunocompetition SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1184 MSX1 Blocking Peptide (AC1184) 250 µg inquiry ACPP-1442 Human TBCB Protein (AC1442) 5 µg inquiry ACPP-1230 MC3 Receptor Blocking Peptide (AC1230) 250 µg inquiry ACPP-1031 Recombinant Human CD24 Protein (Fc Tag) (AC1031) 50 µg inquiry ACPP-1497 Human AMIGO2 Protein (AC1497) 2 µg inquiry ACPP-1536 Human EFNB1 Protein (AC1536) 5 µg inquiry ACPP-1485 Rat VEGF C Protein (152 a.a.) (AC1485) 2 µg inquiry ACPP-1798 Human LMX1B Protein (AC1798) 5 µg inquiry ACPP-1799 Human SNAP23 Protein (AC1799) 5 µg inquiry ACPP-1797 Human S100A5 Protein (AC1797) 5 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket